ELGX Endologix Inc

Endologix, Inc. (NASDAQ: ELGX) announces the following Webcast:

What: � � Lippert/Heilshorn Life Sciences Conference Presentation When: March 26, 2009 @ 9:30 AM Eastern Where:

http://www.investorcalendar.com/ClientPage.asp?ID=142691

How: Live over the Internet -- Simply log on to the web at the address above. Contact:

Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.com

If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=142691 or http://www.investorcalendar.com/

Endologix, Inc. develops and manufactures innovative therapies for aortic disorders. AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.